Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)
Public ClinicalTrials.gov record NCT06456346. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-blind, Active-Comparator-Controlled Clinical Study to Evaluate the Efficacy and Safety of Bomedemstat (MK-3543) Versus Hydroxyurea in Cytoreductive Therapy Naïve Essential Thrombocythemia Participants
Study identification
- NCT ID
- NCT06456346
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Merck Sharp & Dohme LLC
- Industry
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Interventions
- Bomedemstat Drug
- Bomedemstat placebo Drug
- Hydroxyurea Drug
- Hydroxyurea placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 15, 2024
- Primary completion
- Sep 27, 2027
- Completion
- Mar 23, 2028
- Last update posted
- Apr 22, 2026
2024 – 2028
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Palo Verde Cancer Specialists ( Site 0052) | Glendale | Arizona | 85304 | Recruiting |
| Los Angeles Cancer Network ( Site 0025) | Glendale | California | 91206 | Recruiting |
| Stanford Cancer Center ( Site 0024) | Palo Alto | California | 94304 | Recruiting |
| Exempla Lutheran Medical Center ( Site 0014) | Golden | Colorado | 80401 | Recruiting |
| Yale University School of Medicine ( Site 0051) | New Haven | Connecticut | 06510 | Recruiting |
| Parkview Research Center at Parkview Regional Medical Center ( Site 0006) | Fort Wayne | Indiana | 46845 | Completed |
| University of Michigan ( Site 0003) | Ann Arbor | Michigan | 48109 | Recruiting |
| Optum Care Cancer Center ( Site 0053) | Las Vegas | Nevada | 89102 | Recruiting |
| Levine Cancer Institute ( Site 0009) | Charlotte | North Carolina | 28204 | Recruiting |
| Duke University Health System (DUHS) ( Site 0012) | Durham | North Carolina | 27710 | Recruiting |
| Wake Forest Baptist Health-Internal Medicine, Section on Hematology & Oncology ( Site 0013) | Winston-Salem | North Carolina | 27157 | Recruiting |
| The Ohio State University Wexner Medical Center ( Site 0028) | Columbus | Ohio | 43210 | Recruiting |
| Oregon Health & Science University ( Site 0018) | Portland | Oregon | 97239 | Recruiting |
| University of Texas MD Anderson Cancer Center ( Site 0026) | Houston | Texas | 77030 | Recruiting |
| University of Texas Health Science Center at San Antonio ( Site 0021) | San Antonio | Texas | 78229 | Recruiting |
| University of Virginia ( Site 0020) | Charlottesville | Virginia | 22908 | Recruiting |
| VCU Health Adult Outpatient Pavillion ( Site 0008) | Richmond | Virginia | 23219 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 149 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06456346, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 22, 2026 · Synced Apr 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06456346 live on ClinicalTrials.gov.